Market closedNon-fractional
The Joint Corp./JYNT
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About The Joint Corp.
The Joint Corp develops, owns, operates, supports, and manages chiropractic clinics through direct ownership, management arrangements, franchising, and the sales of regional developer rights throughout the United States. The doctors of chiropractic develop personalized treatment plans to relieve patients' pain and deliver ongoing preventative care. The Company has two operating business segments; the Corporate Clinics segment is comprised of the operating activities of the company-owned or managed clinics, and The Franchise Operations segment is comprised of the operating activities of the franchise business unit. The company generates maximum revenue from the Corporate clinic's segment.
Ticker
JYNT
Sector
Healthcare
Trading on
NASDAQ
Industry
Health Care Providers and Services
Headquarters
Scottsdale, United States
Employees
619
Website
www.thejoint.com
The Joint Corp. Metrics
BasicAdvanced
$204M
Market cap
-
P/E ratio
-$0.76
EPS
1.58
Beta
-
Dividend rate
Price and volume
Market cap
$204M
Beta
1.58
Financial strength
Current ratio
1.338
Quick ratio
0.66
Long term debt to equity
40.596
Total debt to equity
55.006
Interest coverage (TTM)
146.57%
Management effectiveness
Return on assets (TTM)
1.75%
Return on equity (TTM)
-36.19%
Valuation
Price to revenue (TTM)
1.687
Price to book
7.76
Price to tangible book (TTM)
14.13
Price to free cash flow (TTM)
27.65
Growth
Revenue change (TTM)
11.00%
Earnings per share change (TTM)
-484.16%
3-year revenue growth (CAGR)
23.93%
3-year earnings per share growth (CAGR)
-8.59%
What the Analysts think about The Joint Corp.
Analyst Ratings
Majority rating from 5 analysts.
The Joint Corp. Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$30M
-2.94%
Net income
$900K
-108.18%
Profit margin
3.03%
-108.43%
The Joint Corp. Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.01
-$0.05
-$0.75
$0.06
-
Expected
$0.01
$0.02
$0.01
-$0.01
-$0.02
Surprise
-200.00%
-377.78%
-6,350.00%
-1,100.00%
-
The Joint Corp. News
AllArticlesVideos
The Joint Corp. to Host Conference Call on Thursday, August 8th to Discuss Second Quarter 2024 Results
GlobeNewsWire·2 days ago
The Joint Corp. Engages Capstone Partners to Accelerate Refranchising Efforts
GlobeNewsWire·2 months ago
The Joint Corp. to Participate in Upcoming Investor Conferences
GlobeNewsWire·3 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for The Joint Corp. stock?
The Joint Corp. (JYNT) has a market cap of $204M as of July 27, 2024.
What is the P/E ratio for The Joint Corp. stock?
The price to earnings (P/E) ratio for The Joint Corp. (JYNT) stock is 0 as of July 27, 2024.
Does The Joint Corp. stock pay dividends?
No, The Joint Corp. (JYNT) stock does not pay dividends to its shareholders as of July 27, 2024.
When is the next The Joint Corp. dividend payment date?
The Joint Corp. (JYNT) stock does not pay dividends to its shareholders.
What is the beta indicator for The Joint Corp.?
The Joint Corp. (JYNT) has a beta rating of 1.58. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.
Buy or sell The Joint Corp. stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.